Fiera Capital (Canada) Portfolio holdings
AUM
$29.5B
1-Year Return
18.02%
This Quarter Return
+7.48%
1 Year Return
+18.02%
3 Year Return
+72.89%
5 Year Return
+140.65%
10 Year Return
+368.22%
AUM
$33.3B
AUM Growth
+$992M
(+3.1%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
40.02%
Holding
495
New
50
Increased
154
Reduced
221
Closed
39
Top Buys
| 1 |
Murphy USA
MUSA
|
+$53.4M |
| 2 |
Lennox International
LII
|
+$50.5M |
| 3 |
Rollins
ROL
|
+$43.2M |
| 4 |
Bentley Systems
BSY
|
+$42.8M |
| 5 |
Texas Roadhouse
TXRH
|
+$41.7M |
Top Sells
| 1 |
Nike
NKE
|
+$190M |
| 2 |
TSMC
TSM
|
+$185M |
| 3 |
Edwards Lifesciences
EW
|
+$110M |
| 4 |
Moody's
MCO
|
+$76.8M |
| 5 |
Microsoft
MSFT
|
+$69.6M |
Sector Composition
| 1 | Technology | 22.12% |
| 2 | Financials | 21.5% |
| 3 | Industrials | 16% |
| 4 | Healthcare | 11.52% |
| 5 | Consumer Discretionary | 11.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Lightspeed Commerce
LSPD
$1.6B
| $644K | ﹤0.01% |
39,000
| – | – |
|
377
Blue Owl Capital
OWL
$12.2B
| $639K | ﹤0.01% |
33,002
+332
| +1% | +$6.43K |
|
378
Exxon Mobil
XOM
$479B
| $635K | ﹤0.01% |
5,419
+433
| +9% | +$50.8K |
|
379
Pfizer
PFE
$136B
| $631K | ﹤0.01% |
21,805
-593
| -3% | -$17.2K |
|
380
Merck
MRK
$208B
| $624K | ﹤0.01% |
5,494
+629
| +13% | +$71.4K |
|
381
Manulife Financial
MFC
$54B
| $618K | ﹤0.01% |
20,898
-76,444
| -79% | -$2.26M |
|
382
Shopify
SHOP
$186B
| $550K | ﹤0.01% |
6,858
-66
| -1% | -$5.29K |
|
383
L3Harris
LHX
$52.3B
| $546K | ﹤0.01% |
2,297
-45
| -2% | -$10.7K |
|
384
Progressive
PGR
$146B
| $533K | ﹤0.01% |
2,101
+24
| +1% | +$6.09K |
|
385
Invesco High Income Trust II
VLT
$73.5M
| $527K | ﹤0.01% |
+45,700
| New | +$527K |
|
386
Leidos
LDOS
$23.7B
| $525K | ﹤0.01% |
+3,221
| New | +$525K |
|
387
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.7B
| $523K | ﹤0.01% |
4,630
-312
| -6% | -$35.3K |
|
388
Allstate
ALL
$52.9B
| $519K | ﹤0.01% |
+2,735
| New | +$519K |
|
389
United Therapeutics
UTHR
$18.3B
| $517K | ﹤0.01% |
+1,444
| New | +$517K |
|
|
CIK
390
Credit Suisse Asset Management Income Fund
CIK
$164M
| $514K | ﹤0.01% |
166,450
+141,044
| +555% | +$436K |
|
|
PHD
391
Pioneer Floating Rate Fund
PHD
$122M
| $508K | ﹤0.01% |
+51,360
| New | +$508K |
|
392
Cardinal Health
CAH
$36.3B
| $507K | ﹤0.01% |
+4,591
| New | +$507K |
|
393
Kroger
KR
$45.3B
| $507K | ﹤0.01% |
8,840
+1,290
| +17% | +$73.9K |
|
394
Nuveen Mortgage and Income Fund
JLS
$104M
| $506K | ﹤0.01% |
+27,448
| New | +$506K |
|
395
Kellanova
K
$27.6B
| $504K | ﹤0.01% |
6,239
-1,351
| -18% | -$109K |
|
396
Check Point Software Technologies
CHKP
$21B
| $502K | ﹤0.01% |
2,606
+36
| +1% | +$6.94K |
|
397
General Mills
GIS
$26.7B
| $498K | ﹤0.01% |
6,745
+540
| +9% | +$39.9K |
|
398
CF Industries
CF
$13.9B
| $494K | ﹤0.01% |
+5,762
| New | +$494K |
|
399
Bristol-Myers Squibb
BMY
$94.2B
| $492K | ﹤0.01% |
9,511
+961
| +11% | +$49.7K |
|
400
Northrop Grumman
NOC
$82.7B
| $491K | ﹤0.01% |
930
-5
| -0.5% | -$2.64K |
|